Clinical Trial Update: European Long-acting Antipsychotics in Schizophrenia Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on European long-acting antipsychotics in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: UMC Utrecht | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED